APO Research
Talk to an analyst

APO RESEARCH · REPORT

Obeticholic Acid Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Obeticholic Acid Drug Market Outlook and Growth Opportunities 2026

2 January 2026197 pages

Choose your research edition.

Industry ResearchObeticholic Acid Drug Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Obeticholic Acid Drug Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Obeticholic Acid Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Obeticholic Acid Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Obeticholic Acid Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Obeticholic Acid Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Obeticholic Acid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Obeticholic Acid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Obeticholic Acid Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Obeticholic Acid Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Obeticholic Acid Drug market include Intercept Pharmaceuticals and Dainippon Sumitomo Pharma among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Obeticholic Acid Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Obeticholic Acid Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Obeticholic Acid Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Obeticholic Acid Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Obeticholic Acid Drug Segment by Company

Intercept Pharmaceuticals

Dainippon Sumitomo Pharma

Obeticholic Acid Drug Segment by Type

5mg

10mg

Obeticholic Acid Drug Segment by Application

Primary Biliary Cirrhosis

Nonalcoholic Fatty Liver Disease

Other

Obeticholic Acid Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Obeticholic Acid Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Obeticholic Acid Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Obeticholic Acid Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Obeticholic Acid Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obeticholic Acid Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Obeticholic Acid Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obeticholic Acid Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Obeticholic Acid Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Obeticholic Acid Drug industry.

Chapter 3: Detailed analysis of Obeticholic Acid Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Obeticholic Acid Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Obeticholic Acid Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Obeticholic Acid Drug Industry Trends Table 2. Obeticholic Acid Drug Industry Drivers Table 3. Obeticholic Acid Drug Industry Opportunities and Challenges Table 4. Obeticholic Acid Drug Industry Restraints Table 5. Global Obeticholic Acid Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Obeticholic Acid Drug Revenue Share by Company (2021-2026) Table 7. Global Obeticholic Acid Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Obeticholic Acid Drug Sales Volume Share by Company (2021-2026) Table 9. Global Obeticholic Acid Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Obeticholic Acid Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Obeticholic Acid Drug Key Company Manufacturing Base & Headquarters Table 12. Global Obeticholic Acid Drug Company, Product Type & Application Table 13. Global Obeticholic Acid Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Obeticholic Acid Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5mg Table 18. Significant Companies of 10mg Table 19. Global Obeticholic Acid Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Obeticholic Acid Drug Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Obeticholic Acid Drug Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Obeticholic Acid Drug Sales Volume Share by Type (2021-2026) Table 23. Global Obeticholic Acid Drug Sales Volume Share by Type (2027-2032) Table 24. Global Obeticholic Acid Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Obeticholic Acid Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Obeticholic Acid Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Obeticholic Acid Drug Sales Value Share by Type (2021-2026) Table 28. Global Obeticholic Acid Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Primary Biliary Cirrhosis Table 30. Significant Companies of Nonalcoholic Fatty Liver Disease Table 31. Significant Companies of Other Table 32. Global Obeticholic Acid Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Obeticholic Acid Drug Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Obeticholic Acid Drug Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Obeticholic Acid Drug Sales Volume Share by Application (2021-2026) Table 36. Global Obeticholic Acid Drug Sales Volume Share by Application (2027-2032) Table 37. Global Obeticholic Acid Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Obeticholic Acid Drug Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Obeticholic Acid Drug Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Obeticholic Acid Drug Sales Value Share by Application (2021-2026) Table 41. Global Obeticholic Acid Drug Sales Value Share by Application (2027-2032) Table 42. Global Obeticholic Acid Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Obeticholic Acid Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Obeticholic Acid Drug Sales Market Share by Region (2021-2026) Table 45. Global Obeticholic Acid Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Obeticholic Acid Drug Sales Market Share by Region (2027-2032) Table 47. Global Obeticholic Acid Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Obeticholic Acid Drug Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Obeticholic Acid Drug Sales Value Share by Region (2021-2026) Table 50. Global Obeticholic Acid Drug Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Obeticholic Acid Drug Sales Value Share by Region (2027-2032) Table 52. Global Obeticholic Acid Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Obeticholic Acid Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Obeticholic Acid Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Obeticholic Acid Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Obeticholic Acid Drug Sales by Country (2021-2026) & (K Units) Table 57. Global Obeticholic Acid Drug Sales Market Share by Country (2021-2026) Table 58. Global Obeticholic Acid Drug Sales by Country (2027-2032) & (K Units) Table 59. Global Obeticholic Acid Drug Sales Market Share by Country (2027-2032) Table 60. Global Obeticholic Acid Drug Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Obeticholic Acid Drug Sales Value Market Share by Country (2021-2026) Table 62. Global Obeticholic Acid Drug Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Obeticholic Acid Drug Sales Value Market Share by Country (2027-2032) Table 64. Intercept Pharmaceuticals Company Information Table 65. Intercept Pharmaceuticals Business Overview Table 66. Intercept Pharmaceuticals Obeticholic Acid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Intercept Pharmaceuticals Obeticholic Acid Drug Product Portfolio Table 68. Intercept Pharmaceuticals Recent Development Table 69. Dainippon Sumitomo Pharma Company Information Table 70. Dainippon Sumitomo Pharma Business Overview Table 71. Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Dainippon Sumitomo Pharma Obeticholic Acid Drug Product Portfolio Table 73. Dainippon Sumitomo Pharma Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Obeticholic Acid Drug Distributors List Table 77. Obeticholic Acid Drug Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Obeticholic Acid Drug Product Image Figure 2. Global Obeticholic Acid Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Obeticholic Acid Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Obeticholic Acid Drug Sales (2021-2032) & (K Units) Figure 5. Global Obeticholic Acid Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Obeticholic Acid Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5mg Image Figure 10. 10mg Image Figure 11. Global Obeticholic Acid Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Obeticholic Acid Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Obeticholic Acid Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Obeticholic Acid Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Obeticholic Acid Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Obeticholic Acid Drug Sales Value Share by Type (2021-2032) Figure 17. Primary Biliary Cirrhosis Image Figure 18. Nonalcoholic Fatty Liver Disease Image Figure 19. Other Image Figure 20. Global Obeticholic Acid Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Obeticholic Acid Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Obeticholic Acid Drug Sales Volume Share by Application (2021-2032) Figure 23. Global Obeticholic Acid Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Obeticholic Acid Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Obeticholic Acid Drug Sales Value Share by Application (2021-2032) Figure 26. Global Obeticholic Acid Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Obeticholic Acid Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Obeticholic Acid Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Obeticholic Acid Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Obeticholic Acid Drug Sales Value (2021-2032) & (US$ Million) Figure 31. North America Obeticholic Acid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Obeticholic Acid Drug Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Obeticholic Acid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Obeticholic Acid Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Obeticholic Acid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Obeticholic Acid Drug Sales Value (2021-2032) & (US$ Million) Figure 37. South America Obeticholic Acid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Obeticholic Acid Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Obeticholic Acid Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Obeticholic Acid Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Obeticholic Acid Drug Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Obeticholic Acid Drug Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
Applications
  • Primary Biliary Cirrhosis
  • Nonalcoholic Fatty Liver Disease
  • Other
Companies covered
  • Intercept Pharmaceuticals
  • Dainippon Sumitomo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Obeticholic Acid Drug Sales Value (2021-2032)
  4. 1.2.2 Global Obeticholic Acid Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Obeticholic Acid Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Obeticholic Acid Drug Market Dynamics
  1. 2.1 Obeticholic Acid Drug Industry Trends
  2. 2.2 Obeticholic Acid Drug Industry Drivers
  3. 2.3 Obeticholic Acid Drug Industry Opportunities and Challenges
  4. 2.4 Obeticholic Acid Drug Industry Restraints
3 Obeticholic Acid Drug Market by Company
  1. 3.1 Global Obeticholic Acid Drug Company Revenue Ranking in 2025
  2. 3.2 Global Obeticholic Acid Drug Revenue by Company (2021-2026)
  3. 3.3 Global Obeticholic Acid Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Obeticholic Acid Drug Average Price by Company (2021-2026)
  5. 3.5 Global Obeticholic Acid Drug Company Ranking (2024-2026)
  6. 3.6 Global Obeticholic Acid Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Obeticholic Acid Drug Company Product Type and Application
  8. 3.8 Global Obeticholic Acid Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Obeticholic Acid Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Obeticholic Acid Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Obeticholic Acid Drug Market by Type
  1. 4.1 Obeticholic Acid Drug Type Introduction
  2. 4.1.1 5mg
  3. 4.1.2 10mg
  4. 4.2 Global Obeticholic Acid Drug Sales Volume by Type
  5. 4.2.1 Global Obeticholic Acid Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Obeticholic Acid Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Obeticholic Acid Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Obeticholic Acid Drug Sales Value by Type
  9. 4.3.1 Global Obeticholic Acid Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Obeticholic Acid Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Obeticholic Acid Drug Sales Value Share by Type (2021-2032)
5 Obeticholic Acid Drug Market by Application
  1. 5.1 Obeticholic Acid Drug Application Introduction
  2. 5.1.1 Primary Biliary Cirrhosis
  3. 5.1.2 Nonalcoholic Fatty Liver Disease
  4. 5.1.3 Other
  5. 5.2 Global Obeticholic Acid Drug Sales Volume by Application
  6. 5.2.1 Global Obeticholic Acid Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Obeticholic Acid Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Obeticholic Acid Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Obeticholic Acid Drug Sales Value by Application
  10. 5.3.1 Global Obeticholic Acid Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Obeticholic Acid Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Obeticholic Acid Drug Sales Value Share by Application (2021-2032)
6 Obeticholic Acid Drug Regional Sales and Value Analysis
  1. 6.1 Global Obeticholic Acid Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Obeticholic Acid Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Obeticholic Acid Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Obeticholic Acid Drug Sales by Region (2027-2032)
  5. 6.3 Global Obeticholic Acid Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Obeticholic Acid Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Obeticholic Acid Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Obeticholic Acid Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Obeticholic Acid Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Obeticholic Acid Drug Sales Value (2021-2032)
  12. 6.6.2 North America Obeticholic Acid Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Obeticholic Acid Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Obeticholic Acid Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Obeticholic Acid Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Obeticholic Acid Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Obeticholic Acid Drug Sales Value (2021-2032)
  21. 6.9.2 South America Obeticholic Acid Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Obeticholic Acid Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Obeticholic Acid Drug Sales Value Share by Country, 2025 VS 2032
7 Obeticholic Acid Drug Country-level Sales and Value Analysis
  1. 7.1 Global Obeticholic Acid Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Obeticholic Acid Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Obeticholic Acid Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Obeticholic Acid Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Obeticholic Acid Drug Sales by Country (2027-2032)
  6. 7.4 Global Obeticholic Acid Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Obeticholic Acid Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Obeticholic Acid Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Obeticholic Acid Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Obeticholic Acid Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Obeticholic Acid Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Intercept Pharmaceuticals
  2. 8.1.1 Intercept Pharmaceuticals Company Information
  3. 8.1.2 Intercept Pharmaceuticals Business Overview
  4. 8.1.3 Intercept Pharmaceuticals Obeticholic Acid Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Intercept Pharmaceuticals Obeticholic Acid Drug Product Portfolio
  6. 8.1.5 Intercept Pharmaceuticals Recent Developments
  7. 8.2 Dainippon Sumitomo Pharma
  8. 8.2.1 Dainippon Sumitomo Pharma Company Information
  9. 8.2.2 Dainippon Sumitomo Pharma Business Overview
  10. 8.2.3 Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dainippon Sumitomo Pharma Obeticholic Acid Drug Product Portfolio
  12. 8.2.5 Dainippon Sumitomo Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Obeticholic Acid Drug Value Chain Analysis
  2. 9.1.1 Obeticholic Acid Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Obeticholic Acid Drug Sales Mode & Process
  6. 9.2 Obeticholic Acid Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Obeticholic Acid Drug Distributors
  9. 9.2.3 Obeticholic Acid Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst